107 related articles for article (PubMed ID: 8348061)
1. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.
Tangrea JA; Adrianza E; Helsel WE; Taylor PR; Hartman AM; Peck GL; Edwards BK
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):375-80. PubMed ID: 8348061
[TBL] [Abstract][Full Text] [Related]
2. Patients' perceptions on participation in a cancer chemoprevention trial.
Tangrea JA; Adrianza ME; Helsel WE
Cancer Epidemiol Biomarkers Prev; 1992; 1(4):325-30. PubMed ID: 1303133
[TBL] [Abstract][Full Text] [Related]
3. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
[TBL] [Abstract][Full Text] [Related]
4. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
Zane LT; Leyden WA; Marqueling AL; Manos MM
Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
[TBL] [Abstract][Full Text] [Related]
5. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group.
Tangrea JA; Edwards BK; Taylor PR; Hartman AM; Peck GL; Salasche SJ; Menon PA; Benson PM; Mellette JR; Guill MA
J Natl Cancer Inst; 1992 Mar; 84(5):328-32. PubMed ID: 1738183
[TBL] [Abstract][Full Text] [Related]
6. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin.
Fine JD; Johnson LB; Weiner M; Stein A; Suchindran C
J Am Acad Dermatol; 2004 Apr; 50(4):563-71. PubMed ID: 15034505
[TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
9. An observational study of isotretinoin recipients treated for acne in a health maintenance organization.
McElwee NE; Schumacher MC; Johnson SC; Weir TW; Greene SL; Scotvold MJ; Hunter JR; Dinan BJ; Jick H
Arch Dermatol; 1991 Mar; 127(3):341-6. PubMed ID: 1825596
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.
Tangrea J; Edwards B; Hartman A; Taylor P; Peck G; Salasche S; Menon P; Winton G; Mellette R; Guill M
Control Clin Trials; 1990 Dec; 11(6):433-50. PubMed ID: 1963135
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
12. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin does not prevent basal cell carcinoma.
Robinson JK; Salasche SJ
Arch Dermatol; 1992 Jul; 128(7):975-6. PubMed ID: 1626967
[No Abstract] [Full Text] [Related]
14. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.
Jones E; Korzenko A; Kriegel D
J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients.
Campbell RM; DiGiovanna JJ
Dermatol Ther; 2006; 19(5):306-14. PubMed ID: 17014486
[TBL] [Abstract][Full Text] [Related]
16. Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin.
Tangrea JA; Kilcoyne RF; Taylor PR; Helsel WE; Adrianza ME; Hartman AM; Edwards BK; Peck GL
Arch Dermatol; 1992 Jul; 128(7):921-5. PubMed ID: 1626958
[TBL] [Abstract][Full Text] [Related]
17. Low-dose isotretinoin in the treatment of acne vulgaris.
Amichai B; Shemer A; Grunwald MH
J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
19. Safety assessment of raloxifene over eight years in a clinical trial setting.
Martino S; Disch D; Dowsett SA; Keech CA; Mershon JL
Curr Med Res Opin; 2005 Sep; 21(9):1441-52. PubMed ID: 16197663
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
